3CTN-funded clinical trial to test new method of finding genomic changes in patients with aggressive prostate cancer

OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers

OICR extends collaboration with Janssen Inc. to develop clinical trials for prostate cancer